A detailed history of Mission Wealth Management, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mission Wealth Management, LP holds 33,142 shares of BMY stock, worth $1.93 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
33,142
Previous 22,338 48.37%
Holding current value
$1.93 Million
Previous $927,000 85.01%
% of portfolio
0.04%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $428,486 - $559,107
10,804 Added 48.37%
33,142 $1.72 Million
Q2 2024

Aug 02, 2024

SELL
$40.25 - $52.99 $845 - $1,112
-21 Reduced 0.09%
22,338 $927,000
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $91,305 - $103,523
1,903 Added 9.3%
22,359 $1.21 Million
Q4 2023

Feb 05, 2024

SELL
$48.48 - $57.85 $22,591 - $26,958
-466 Reduced 2.23%
20,456 $1.05 Million
Q3 2023

Oct 23, 2023

SELL
$57.89 - $64.73 $91,987 - $102,855
-1,589 Reduced 7.06%
20,922 $1.21 Million
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $38,926 - $43,222
-611 Reduced 2.64%
22,511 $1.44 Million
Q1 2023

Apr 07, 2023

SELL
$65.71 - $74.53 $14,850 - $16,843
-226 Reduced 0.97%
23,122 $1.6 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $6,984 - $8,271
102 Added 0.44%
23,348 $1.68 Million
Q3 2022

Oct 12, 2022

BUY
$0.13 - $76.84 $195 - $115,260
1,500 Added 6.9%
23,246 $1.65 Million
Q2 2022

Jul 27, 2022

BUY
$72.62 - $79.98 $97,746 - $107,653
1,346 Added 6.6%
21,746 $1.67 Million
Q1 2022

Apr 25, 2022

SELL
$61.48 - $73.72 $17,767 - $21,305
-289 Reduced 1.4%
20,400 $1.49 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $3,325 - $3,876
62 Added 0.3%
20,689 $1.29 Million
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $203,308 - $238,149
-3,436 Reduced 14.28%
20,627 $1.22 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $135,149 - $147,177
-2,183 Reduced 8.32%
24,063 $1.61 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $253,263 - $284,846
4,268 Added 19.42%
26,246 $1.66 Million
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $117,616 - $133,280
2,037 Added 10.22%
21,978 $1.36 Million
Q3 2020

Oct 16, 2020

BUY
$57.43 - $63.64 $333,783 - $369,875
5,812 Added 41.14%
19,941 $1.2 Million
Q2 2020

Aug 03, 2020

BUY
$54.82 - $64.09 $175,424 - $205,088
3,200 Added 29.28%
14,129 $831,000
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $116,000 - $168,575
-2,500 Reduced 18.62%
10,929 $609,000
Q1 2020

Apr 10, 2020

BUY
$46.4 - $67.43 $16,611 - $24,139
358 Added 2.74%
13,429 $749,000
Q4 2019

Jan 21, 2020

BUY
$49.21 - $64.19 $25,441 - $33,186
517 Added 4.12%
13,071 $839,000
Q3 2019

Oct 16, 2019

SELL
$42.77 - $50.71 $9,751 - $11,561
-228 Reduced 1.78%
12,554 $637,000
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $83,528 - $92,364
1,872 Added 17.16%
12,782 $580,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $54,369 - $64,829
1,205 Added 12.42%
10,910 $521,000
Q4 2018

Feb 08, 2019

BUY
$48.76 - $63.23 $111,075 - $144,037
2,278 Added 30.67%
9,705 $504,000
Q3 2018

Nov 01, 2018

SELL
$55.19 - $62.25 $702,403 - $792,255
-12,727 Reduced 63.15%
7,427 $461,000
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $178,118 - $222,004
3,525 Added 21.2%
20,154 $1.12 Million
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $34,633 - $39,870
-578 Reduced 3.36%
16,629 $1.05 Million
Q4 2017

Feb 09, 2018

SELL
$59.94 - $65.35 $44,295 - $48,293
-739 Reduced 4.12%
17,207 $1.05 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $2,871 - $3,314
52 Added 0.29%
17,946 $1.14 Million
Q2 2017

Aug 11, 2017

BUY
N/A
17,894
17,894 $997,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.